Overexpression of anti-apoptotic members of the Bcl-2 family, such as Myeloid Cell Leukemia-1 (Mcl-1) and Bcl-2, has been linked to chemotherapy resistance in several cancers, including leukemia, lung cancer, and breast cancer [47, 48]. Here, BCL2 is linked to lung carcinoma.